Stock AGRX AGILE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Market Closed - OTC Markets
Other stock markets
 01:30:27 2024-05-14 pm EDT 		5-day change 1st Jan Change
0.3778 USD -0.59% Intraday chart for Agile Therapeutics, Inc. -8.90% -80.63%
Mar. 28 Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Mar. 28 Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AGILE THERAPEUTICS, INC. Stock Agile Therapeutics, Inc.
 2.59M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. AGRX Stock
  4. Charts Agile Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW